Discovering novel pharmacogenomic biomarkers by imputing drug response in cancer patients from large genomics studies.
about
Gene and MicroRNA Perturbations of Cellular Response to Pemetrexed Implicate Biological Networks and Enable Imputation of Response in Lung Adenocarcinoma.Kernelized rank learning for personalized drug recommendation.Pharmacogenomics and big genomic data: from lab to clinic and back again.Cancer expression quantitative trait loci (eQTLs) can be determined from heterogeneous tumor gene expression data by modeling variation in tumor purity
P2860
Discovering novel pharmacogenomic biomarkers by imputing drug response in cancer patients from large genomics studies.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Discovering novel pharmacogeno ...... s from large genomics studies.
@en
type
label
Discovering novel pharmacogeno ...... s from large genomics studies.
@en
prefLabel
Discovering novel pharmacogeno ...... s from large genomics studies.
@en
P2093
P2860
P356
P1433
P1476
Discovering novel pharmacogeno ...... ts from large genomics studies
@en
P2093
Gladys Morrison
Paul Geeleher
Robert F Gruener
Robert L Grossman
Steven Bhutra
Zhenyu Zhang
P2860
P304
P356
10.1101/GR.221077.117
P577
2017-08-28T00:00:00Z